James E Dentzer Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for James E Dentzer.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of James E Dentzer. James E Dentzer is Chief Financial Officer in CURIS INC ($CRIS) and COO & CFO in CURIS INC ($CRIS) and President & CEO in CURIS INC ($CRIS) and Chief Financial Officer in AMICUS THERAPEUTICS INC ($FOLD) and Chief Financial Officer. in AMICUS THERAPEUTICS INC ($FOLD).
Latest Insider Trading Transactions of James E Dentzer
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 26 2021 | CRIS | CURIS INC | Dentzer James E | President & CEO | Sell | S | 10.59 | 3,094 | 32,758 | 67,268 | 70.4 K to 67.3 K (-4.40 %) |
Jan 26 2021 | CRIS | CURIS INC | Dentzer James E | President & CEO | Sell | S | 10.96 | 2,283 | 25,022 | 70,362 | 72.6 K to 70.4 K (-3.14 %) |
Jan 24 2020 | CRIS | CURIS INC | Dentzer James E | President & CEO | Sell | S | 1.64 | 3,094 | 5,076 | 42,158 | 45.3 K to 42.2 K (-6.84 %) |
Jan 24 2020 | CRIS | CURIS INC | Dentzer James E | President & CEO | Sell | S | 1.69 | 3,658 | 6,182 | 45,252 | 48.9 K to 45.3 K (-7.48 %) |
May 28 2019 | CRIS | CURIS INC | Dentzer James E | President & CEO | Option Exercise | A | 1.16 | 1,115,871 | 1,294,410 | 1,115,871 | |
Jan 25 2019 | CRIS | CURIS INC | Dentzer James E | President & CEO | Sell | S | 1.16 | 3,094 | 3,577 | 41,639 | 44.7 K to 41.6 K (-6.92 %) |
Jan 25 2019 | CRIS | CURIS INC | Dentzer James E | President & CEO | Sell | S | 1.09 | 2,397 | 2,613 | 44,733 | 47.1 K to 44.7 K (-5.09 %) |
Sep 27 2018 | CRIS | CURIS INC | Dentzer James E | President & CEO | Option Exercise | A | 1.62 | 750,000 | 1,215,000 | 750,000 | |
May 17 2018 | CRIS | CURIS INC | Dentzer James E | COO & CFO | Option Exercise | A | 0.69 | 825,000 | 569,250 | 825,000 | |
Jan 24 2018 | CRIS | CURIS INC | Dentzer James E | Chief Financial Off ... | Grant | A | 0.00 | 206,250 | 0 | 212,011 | 5.8 K to 212 K (+3,580.11 %) |
Feb 16 2017 | CRIS | CURIS INC | Dentzer James E | Chief Financial Off ... | Option Exercise | A | 2.63 | 650,000 | 1,709,500 | 650,000 | |
Mar 30 2016 | CRIS | CURIS INC | Dentzer James E | Chief Financial Off ... | Option Exercise | A | 1.51 | 1,700,000 | 2,567,000 | 1,700,000 | |
Oct 01 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 8.75 | 220 | 1,925 | 32,075 | 32.3 K to 32.1 K (-0.68 %) |
Aug 03 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 11.39 | 220 | 2,506 | 32,515 | 32.7 K to 32.5 K (-0.67 %) |
Sep 02 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 9.83 | 220 | 2,163 | 32,295 | 32.5 K to 32.3 K (-0.68 %) |
Jul 01 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 11.45 | 220 | 2,519 | 32,735 | 33 K to 32.7 K (-0.67 %) |
Jun 01 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 6.64 | 220 | 1,461 | 32,955 | 33.2 K to 33 K (-0.66 %) |
May 04 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 8.95 | 220 | 1,969 | 33,175 | 33.4 K to 33.2 K (-0.66 %) |
Apr 02 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 9.13 | 220 | 2,009 | 33,395 | 33.6 K to 33.4 K (-0.65 %) |
Mar 03 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 8.06 | 220 | 1,773 | 33,615 | 33.8 K to 33.6 K (-0.65 %) |
Feb 05 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Option Exercise | A | 10.36 | 54,000 | 559,440 | 54,000 | |
Feb 03 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 8.69 | 220 | 1,912 | 33,835 | 34.1 K to 33.8 K (-0.65 %) |
Jan 05 2009 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 8.00 | 220 | 1,760 | 34,055 | 34.3 K to 34.1 K (-0.64 %) |
Dec 02 2008 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 7.98 | 220 | 1,756 | 34,275 | 34.5 K to 34.3 K (-0.64 %) |
Nov 04 2008 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 10.45 | 220 | 2,299 | 34,495 | 34.7 K to 34.5 K (-0.63 %) |
Oct 02 2008 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 15.10 | 220 | 3,322 | 34,715 | 34.9 K to 34.7 K (-0.63 %) |
Sep 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 13.86 | 220 | 3,049 | 34,935 | 35.2 K to 34.9 K (-0.63 %) |
Aug 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 15.61 | 220 | 3,434 | 35,155 | 35.4 K to 35.2 K (-0.62 %) |
Oct 03 2007 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 17.35 | 2,500 | 43,375 | 37,500 | 40 K to 37.5 K (-6.25 %) |
Page: 1